Below is the 2021 schedule and agenda for the BIO CEO & Investor Conference.

BIO CEO & Investor Digital Conference
Date
  • Show All
Time
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO CEO & Investor Digital Conference
Jump to Day
17 Results
Available On-Demand
9 Meters Biopharma (the “Company”) is focused on developing therapies for gastrointestinal (GI)…
3 clinical stage assets: AMO-02 in Phase III in Myotonic Dystrophy AMO-01 in Phelan McDermid…
Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic…

ERYTECH is a clinical-stage biopharmaceutical company developing innovative red blood cell-based…

Formosa Pharmaceuticals is a Taiwan-based biotechnology firm with international alliances in US and…
Greenwich LifeSciences (Nasdaq: GLSI) is a public biopharmaceutical company located in Houston, TX…
Helixmith Co., Ltd is a gene therapy company with over 20 years experience developing new and…
Humanigen, Inc. is developing its portfolio of clinical and pre-clinical therapies for the…
Neumentum is a privately held pharmaceutical company founded in 2017 focused on non-opioid Pain…
Newron is a biopharmaceutical company focused on the development of novel therapies for patients…
Ocuphire is a clinical-stage ophthalmic biopharmaceutical company focused on developing and…
Prilenia is a clinical stage biotech startup founded in 2018 with the purpose of improving the…
Protalix is a biopharmaceutical company focused on the development and commercialization of…
Saghmos Therapeutics' is developing ST-62516 to prevent cardiorenal complications of contrast…
VBL Therapeutics is a publicly traded (NASDAQ: VBLT), late-stage clinical biopharmaceutical company…
Venatorx Pharmaceuticals is a private pharmaceutical company focused on improving health outcomes…

XORTX Therapeutics Inc. is a biopharmaceutical company focused on developing therapies to treat…